Epidemiology of familial multiple sclerosis in Hungary

The prevalence of familial aggregation of multiple sclerosis (MS) is estimated between 5 and 10%. Studies emphasize the effect of genetic factors over the environment of the patients in the development of the disease. We investigated familial accumulation of MS in the cases of 1500 patients in five...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis 2007-03, Vol.13 (2), p.260-261
Main Authors: Fricska-Nagy, Z, Bencsik, K, Rajda, C, Füvesi, J, Honti, V, Csépány, T, Dobos, E, Mátyás, K, Rózsa, C, Komoly, S, Vécsei, L
Format: Article
Language:English
Subjects:
Biological and medical sciences
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Family
Female
Genetic Predisposition to Disease - epidemiology
Humans
Hungary - epidemiology
Immunomodulators
Male
Medical sciences
Multiple Sclerosis - epidemiology
Multiple Sclerosis - genetics
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Neurology
Pharmacology. Drug treatments
Prevalence
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The prevalence of familial aggregation of multiple sclerosis (MS) is estimated between 5 and 10%. Studies emphasize the effect of genetic factors over the environment of the patients in the development of the disease. We investigated familial accumulation of MS in the cases of 1500 patients in five Hungarian MS centers. According to our data, the risk of familial MS in Hungary is lower than in other countries for which literature data are accessible. The literature does not contain any data for the prevalence of familial MS in Hungary and middle-eastern Europe. Multiple Sclerosis 2007; 13: 260–261. http://msj.sagepub.com
ISSN:1352-4585
1477-0970
DOI:10.1177/1352458506070767